AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Glimebees-M 1 SR Tablet

Prescription Icon
Prescription Required

Marketer

Amcare Pharmaceuticals

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimebees-M 1 SR Tablet

Metformin-glimepiride extended-release tablets are antidiabetic medications combining two agents to manage type 2 diabetes in adults. This dual-action therapy helps regulate blood glucose. These tablets should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to hyperglycemia and potentially serious complications including nephropathy, retinopathy, neuropathy, and peripheral vascular disease. This medication is one component of a comprehensive diabetes management plan incorporating diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are vital for diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, manifested by symptoms like sweating, dizziness, headache, and tremors. Prompt recognition and treatment are essential; maintain regular meals and carry a rapid-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Glimebees-M 1 SR Tablet

Managing Type 2 Diabetes

Major Benefits of Glimebees-M 1 SR Tablet:

Follow your doctor's instructions or refer to the product labeling for guidance. Consume Glimebees-M 1 SR Tablet with a meal.

Common Side effects of Glimebees-M 1 SR Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimebees-M 1 SR Tablet:

Follow your physician's instructions or consult the product information leaflet for usage guidelines. Administer Glimebees-M 1 SR Tablet with a meal.

How Glimebees-M 1 SR Tablet works:

Glimebees-M 1 SR combines glimepiride, a sulfonylurea, and metformin, a biguanide, to manage blood sugar. Glimepiride stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glimebees-M 1 SR Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimebees-M 1 SR Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice before taking this drug.

Breast feedingBreast feedingUNSAFE

Lactation and Glimebees-M 1 SR Tablet are incompatible. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimebees-M 1 SR Tablet cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult your physician. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimebees-M 1 SR Tablets cautiously, potentially requiring dose modification. A physician's consultation is recommended. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Glimebees-M 1 SR Tablet :

Should you forget a Glimebees-M 1 SR Tablet, take it immediately. If your next dose is nearly due, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glimebees-M 1 SR Tablet

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Glimebees-M 1 SR Tablet

Maintain this medication within its original, sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Ensure it remains inaccessible to children, pets, and others.
Indeed, Glimebees-M 1 SR Tablet use can result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed MALA (Metformin-associated lactic acidosis), this rare but potentially harmful side effect of metformin is particularly concerning for individuals with pre-existing kidney impairment, the elderly, or those who consume substantial alcohol. Lactic acidosis symptoms can manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, emesis, abdominal discomfort, or bradycardia. Should these symptoms appear, discontinue Glimebees-M 1 SR Tablet use and seek immediate medical attention.
Glimepiride and Metformin, combined as Glimebees-M 1 SR Tablet, manage type 2 diabetes mellitus (DM) in adults. This dual-action therapy enhances blood glucose control when coupled with a healthy diet and regular physical activity. Glimepiride stimulates pancreatic insulin secretion to reduce blood glucose, while Metformin decreases hepatic glucose production and improves insulin responsiveness. This medication is unsuitable for type 1 DM.
Glimebees-M 1 SR Tablet may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headache. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Prolonged Glimepiride-Metformin extended-release tablet use can indeed lead to vitamin B12 deficiency due to impaired gastrointestinal absorption. This deficiency, if left unaddressed, may result in anemia, neurological complications such as paresthesia in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and gait instability. Preventive measures proposed by some studies include annual supplemental vitamin B12 intake.
Glimebees-M 1 SR Tablet can indeed induce hypoglycemia, characterized by low blood sugar. Manifestations of this condition may encompass nausea, headache, irritability, increased hunger, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The likelihood of hypoglycemia increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice, is recommended.
Combining Glimebees-M 1 SR Tablet and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia) and a heightened likelihood of lactic acidosis.
Glimebees-M 1 SR Tablet
51
MRP 62
17% off